NCT05411744View on ClinicalTrials.gov

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2029

Conditions
Latent TuberculosisEnd Stage Renal DiseaseRenal Transplant Candidate for Right KidneyRenal Transplant Candidate for Left Kidney
Interventions
DRUG

1 month Rifapentine, Isoniazid and Vitamin B6

Participants will be treated with one month (4 weeks) of daily Isoniazid, Rifapentine and Vitamin B6.

Trial Locations (1)

08901

RECRUITING

Pinki J Bhatt, New Brunswick

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER